Year |
Citation |
Score |
2019 |
Hernandez M, Recalde S, Garcia-Garcia L, Bezunartea J, Miskey C, Johnen S, Diarra S, Sebe A, Rodriguez-Madoz JR, Pouillot S, Marie C, Izsvák Z, Scherman D, Kropp M, Prosper F, et al. Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization. Molecular Therapy. Methods & Clinical Development. 15: 403-417. PMID 31890733 DOI: 10.1016/J.Omtm.2019.10.013 |
0.371 |
|
2019 |
Fintha A, Gasparics Á, Rosivall L, Sebe A. Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition-An Outstanding Challenge. Frontiers in Pharmacology. 10: 388. PMID 31057405 DOI: 10.3389/Fphar.2019.00388 |
0.315 |
|
2019 |
Schumann GG, Fuchs NV, Tristán-Ramos P, Sebe A, Ivics Z, Heras SR. The impact of transposable element activity on therapeutically relevant human stem cells. Mobile Dna. 10: 9. PMID 30899334 DOI: 10.1186/S13100-019-0151-X |
0.36 |
|
2019 |
Cullmann K, Blokland KEC, Sebe A, Schenk F, Ivics Z, Heinz N, Modlich U. Sustained and regulated gene expression by Tet-inducible "all-in-one" retroviral vectors containing the HNRPA2B1-CBX3 UCOE. Biomaterials. 192: 486-499. PMID 30508767 DOI: 10.1016/J.Biomaterials.2018.11.006 |
0.402 |
|
2017 |
Gasparics Á, Kökény G, Fintha A, Bencs R, Mózes MM, Ágoston EI, Buday A, Ivics Z, Hamar P, Győrffy B, Rosivall L, Sebe A. Alterations in SCAI Expression during Cell Plasticity, Fibrosis and Cancer. Pathology Oncology Research : Por. PMID 28815470 DOI: 10.1007/S12253-017-0293-4 |
0.376 |
|
2017 |
Gasparics Á, Sebe A. MRTFs- master regulators of EMT. Developmental Dynamics : An Official Publication of the American Association of Anatomists. PMID 28681541 DOI: 10.1002/Dvdy.24544 |
0.421 |
|
2017 |
Thumann G, Harmening N, Prat-Souteyrand C, Marie C, Pastor M, Sebe A, Miskey C, Hurst LD, Diarra S, Kropp M, Walter P, Scherman D, Ivics Z, Izsvák Z, Johnen S. Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids. Molecular Therapy. Nucleic Acids. 6: 302-314. PMID 28325297 DOI: 10.1016/J.Omtn.2017.02.002 |
0.363 |
|
2017 |
Winterhoff BJ, Maile M, Mitra AK, Sebe A, Bazzaro M, Geller MA, Abrahante JE, Klein M, Hellweg R, Mullany SA, Beckman K, Daniel J, Starr TK. Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells. Gynecologic Oncology. PMID 28111004 DOI: 10.1016/J.Ygyno.2017.01.015 |
0.334 |
|
2016 |
Gasparics Á, Rosivall L, Krizbai IA, Sebe A. When the endothelium scores an own goal: endothelial cells actively augment metastatic extravasation through endothelial-mesenchymal transition. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00042.2016. PMID 26993222 DOI: 10.1152/Ajpheart.00042.2016 |
0.351 |
|
2016 |
Friedel T, Jung-Klawitter S, Sebe A, Schenk F, Modlich U, Ivics Z, Schumann GG, Buchholz CJ, Schneider IC. CD30 receptor-targeted lentiviral vectors for human induced pluripotent stem cell-specific gene modification. Stem Cells and Development. PMID 26956718 DOI: 10.1089/Scd.2015.0386 |
0.321 |
|
2016 |
Sebe A, Ivics Z. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells with Sleeping Beauty Transposon-Based Stable Gene Delivery. Methods in Molecular Biology (Clifton, N.J.). 1400: 419-27. PMID 26895068 DOI: 10.1007/978-1-4939-3372-3_26 |
0.385 |
|
2016 |
Klawitter S, Fuchs NV, Upton KR, Muñoz-Lopez M, Shukla R, Wang J, Garcia-Cañadas M, Lopez-Ruiz C, Gerhardt DJ, Sebe A, Grabundzija I, Merkert S, Gerdes P, Pulgarin JA, Bock A, et al. Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nature Communications. 7: 10286. PMID 26743714 DOI: 10.1038/Ncomms10286 |
0.347 |
|
2015 |
Krizbai IA, Gasparics Á, Nagyőszi P, Fazakas C, Molnár J, Wilhelm I, Bencs R, Rosivall L, Sebe A. Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation. Plos One. 10: e0119655. PMID 25742314 DOI: 10.1371/Journal.Pone.0119655 |
0.387 |
|
2013 |
Grabundzija I, Wang J, Sebe A, Erdei Z, Kajdi R, Devaraj A, Steinemann D, Szuhai K, Stein U, Cantz T, Schambach A, Baum C, Izsvák Z, Sarkadi B, Ivics Z. Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Research. 41: 1829-47. PMID 23275558 DOI: 10.1093/Nar/Gks1305 |
0.399 |
|
2013 |
Fintha A, Gasparics Á, Fang L, Erdei Z, Hamar P, Mózes MM, Kökény G, Rosivall L, Sebe A. Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition. The American Journal of Pathology. 182: 388-400. PMID 23178076 DOI: 10.1016/J.Ajpath.2012.10.009 |
0.453 |
|
2011 |
Szebényi K, Erdei Z, Péntek A, Sebe A, Orbán TI, Sarkadi B, Apáti Á. Human pluripotent stem cells in pharmacological and toxicological screening: new perspectives for personalized medicine. Personalized Medicine. 8: 347-364. PMID 29783530 DOI: 10.2217/Pme.11.19 |
0.335 |
|
2011 |
Varga Z, Juhász T, Matta C, Fodor J, Katona É, Bartok A, Oláh T, Sebe A, Csernoch L, Panyi G, Zákány R. Switch of voltage-gated K+ channel expression in the plasma membrane of chondrogenic cells affects cytosolic Ca2+-oscillations and cartilage formation. Plos One. 6: e27957. PMID 22132179 DOI: 10.1371/Journal.Pone.0027957 |
0.328 |
|
2010 |
Sebe A, Erdei Z, Varga K, Bodor C, Mucsi I, Rosivall L. Cdc42 regulates myocardin-related transcription factor nuclear shuttling and alpha-smooth muscle actin promoter activity during renal tubular epithelial-mesenchymal transition. Nephron. Experimental Nephrology. 114: e117-25. PMID 20016221 DOI: 10.1159/000265550 |
0.602 |
|
2008 |
Sebe A, Leivonen SK, Fintha A, Masszi A, Rosivall L, Kähäri VM, Mucsi I. Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 23: 1537-45. PMID 18192325 DOI: 10.1093/Ndt/Gfm789 |
0.592 |
|
2008 |
Sebe A, Masszi A, Zulys M, Yeung T, Speight P, Rotstein OD, Nakano H, Mucsi I, Szászi K, Kapus A. Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor. Febs Letters. 582: 291-8. PMID 18154735 DOI: 10.1016/J.Febslet.2007.12.021 |
0.562 |
|
2007 |
Fintha A, Sebe A, Masszi A, Terebessy T, Huszár T, Rosivall L, Mucsi I. Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor. Acta Physiologica Hungarica. 94: 19-30. PMID 17444273 DOI: 10.1556/Aphysiol.94.2007.1-2.4 |
0.561 |
|
2007 |
Fan L, Sebe A, Péterfi Z, Masszi A, Thirone AC, Rotstein OD, Nakano H, McCulloch CA, Szászi K, Mucsi I, Kapus A. Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway. Molecular Biology of the Cell. 18: 1083-97. PMID 17215519 DOI: 10.1091/Mbc.E06-07-0602 |
0.578 |
|
2004 |
Terebessy T, Masszi A, Fintha A, Sebe A, Huszár T, Rosivall L, Mucsi I. Angiotensin II activates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal kinase. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 19: 2184-91. PMID 15238629 DOI: 10.1093/Ndt/Gfh388 |
0.543 |
|
Show low-probability matches. |